‘Lipstick Effect’ Put To Test: Top Beauty And Ingredient Supplier Execs On 2022 Volatility
Optimism varies across leading beauty and personal-care companies amid continuing cost, currency and geopolitical headwinds. HBW Insight provides takes from leaders at L’Oréal, The Estee Lauder Companies, Coty, Ulta, P&G and more in recent sales and earnings presentations.
You may also be interested in...
When the sector worries about regulation it is usually about drug development and registration. But governments also regulate on monopolistic positions in life sciences. Adding to that, national security enforcement is now rising.
Changes have occurred in the management focus within the European Commission’s directorate responsible for medtech but not within the devices leadership; familiar faces remain.
Medicines for Europe calls for the pharmaceutical industry to be excluded from energy restriction policies for winter 2022 in an open letter to EU governance bodies. Inflation and energy costs threaten European drug makers with closures and rationing, says the industry body.